
IASLC/LinkedIn
Jun 9, 2025, 19:26
What Did ASCO 2025 Deliver for Lung Cancer Research? – IASLC
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“What did ASCO 2025 deliver for lung cancer research?
In this episode of Lung Cancer Considered, Drs. Narjust Florez, Stephen Liu, Charu Aggarwal, and Patrick Forde review key lung cancer data from ASCO25 – including the CheckMate 816, HERTHENA-Lung02, NEOADAURA, REZILIENT1, SWOG Pragmatica, IMforte, and SOHO-01 trials.
Get expert analysis on what these results mean for clinical practice and research moving forward! Listen now.”
More posts featuring IASLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 19:26
Jun 9, 2025, 18:29
Jun 9, 2025, 18:21
Jun 9, 2025, 18:16
Jun 9, 2025, 18:14